Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia (Q35979116)

11 August 2017

Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia (English)

1 reference

11 August 2017

0 references

Clostridium difficile

0 references

1 reference

Luke B Connelly

4

0 references

Nicholas Graves

object named as

Nicholas Graves

series ordinal

2

0 references

author name string

Gregory Merlo

series ordinal

1

1 reference

PubMed ID

27043242

11 August 2017

David Brain

series ordinal

3

1 reference

11 August 2017

4 April 2016

1 reference

Journal of Gastroenterology and Hepatology

11 August 2017

1 reference

11 August 2017

31

1 reference

11 August 2017

1927-1932

1 reference

11 August 2017

12

1 reference

Clostridium difficile colitis

11 August 2017

1 reference

Recurrent Clostridium difficile diarrhoea

21 January 2018

1 reference

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

21 January 2018

1 reference

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

21 January 2018

1 reference

Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead.

21 January 2018

1 reference

Duodenal infusion of donor feces for recurrent Clostridium difficile

21 January 2018

1 reference

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

21 January 2018

1 reference

Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study

21 January 2018

1 reference

Gastroenterologist perceptions of faecal microbiota transplantation.

21 January 2018

1 reference

Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile

21 January 2018

1 reference

The potential economic value of screening hospital admissions for Clostridium difficile

21 January 2018

1 reference

The potential value of Clostridium difficile vaccine: an economic computer simulation model

21 January 2018

1 reference

The economic burden of Clostridium difficile

21 January 2018

1 reference

Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease.

21 January 2018

1 reference

Donor Recruitment for Fecal Microbiota Transplantation

21 January 2018

1 reference

Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: clinical efficacy and bacterial viability data

21 January 2018

1 reference

Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook

21 January 2018

1 reference

Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis

21 January 2018

1 reference

Therapeutic potential of fecal microbiota transplantation

21 January 2018

1 reference

An overview of fecal microbiota transplantation: techniques, indications, and outcomes

21 January 2018

1 reference

Policy: How to regulate faecal transplants

21 January 2018

1 reference

Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?

21 January 2018

1 reference

Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.13402

1 reference

11 August 2017

1 reference

PubMed ID

27043242